Results from a first-in-human, proof-of-concept phase 1 trial in pretreated B-cell malignancies for loxo-305, a next-generation, highly selective, non-covalent BTK inhibitor Meeting Abstract
| Authors: | Mato, A. R.; Flinn, I. W.; Pagel, J. M.; Brown, J. R.; Cheah, C. Y.; Coombs, C. C.; Patel, M. R.; Rothenberg, S. M.; Tsai, D. E.; Ku, N. C.; Wang, M. L. |
| Abstract Title: | Results from a first-in-human, proof-of-concept phase 1 trial in pretreated B-cell malignancies for loxo-305, a next-generation, highly selective, non-covalent BTK inhibitor |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000518218500340 |
| DOI: | 10.1182/blood-2019-127509 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 501 -- Source: Wos |
